Alimera Sciences reported $43.43M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Aerie Pharmaceuticals AERI:US USD 375.59M 9.75M
Alimera Sciences ALIM:US USD 43.43M 4.14M
Applied Genetic Technologies AGTC:US USD 57.33M 9.35M
Bayer BAYN:GR EUR 131.01B 2.22B
Insmed INSM:US USD 994.82M 58.54M
Novartis NOVN:VX USD 118.46B 4.45B
Ophthotech OPHT:US USD 331.79M 12.03M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M